Cardiff Oncology, Inc. (CRDF) — research page
US · us-cm-kg/NASDAQ/CRDF · as of 2026-11-08
Identity and listing
The issuer is Cardiff Oncology, Inc., listed on NASDAQ under ticker CRDF, with ISIN US14147L1089 and LEI 549300AHOLZBHHYFWP04. Its security type is Corporate. Segment is not on the record. Sector is 2836 Biological Products, (No Diagnostic Substances). Jurisdiction is United States, Delaware. Status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Cardiff Oncology, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CRDF | source · 2026-11-08 |
| ISIN | US14147L1089 | source · 2026-11-08 |
| LEI | 549300AHOLZBHHYFWP04 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2836 Biological Products, (No Diagnostic Substances) | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 48 filings in the twelve months to 2026-11-08, across 27 filing days. The median gap between filing days is 7.0 days. The latest filing is dated 2026-10-27, 12 days before the record date, and is of type directors_dealings. The NASDAQ median cadence gap is 6.0 days, with a median of 52 filings and a median latency of 5.0 days across 4,359 issuers. The sector median cadence gap is 5.5 days, with a median of 65.5 filings and a median latency of 4.0 days across 176 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 48 | 7 | 12 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2836 Biological Products, (No Diagnostic Substances) (176 issuers) | 65.5 | 5.5 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-27 | directors_dealings | 3 | 3 — 3 |
| 2026-10-27 | director_change | 8-K | 8-K — 8-K (items 5.02,5.03,7.01,9.01) |
| 2026-10-22 | agm_egm | 8-K | 8-K — 8-K (items 5.07) |
| 2026-09-14 | corporate_news | 8-K | 8-K — 8-K (items 1.01,7.01,9.01) |
| 2026-08-26 | agm_egm | DEFA14A | DEFA14A — DEFA14A |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is BDO USA, P.C., located in San Diego, California. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. Domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. Halt flag: listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the investor-relations pages read for this issuer.
Open research
The record holds 2 openly published research notes, both by Noble Capital Markets: dated 2026-01-05 and 2026-02-26.
| date | publisher | note | kind |
|---|---|---|---|
| 2026-02-26 | Noble Capital Markets | Cardiff Oncology FY2025 Reported With Onvansertib Phase 2b Data Review | independent |
| 2026-01-05 | Noble Capital Markets | Initiating Coverage With A $12 Price Target | independent |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
11 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001213037.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/CRDF (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1213037/000119312526067464/crdf-20251231.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260226_28079.pdf (open research)
- 10.10
- https://dashboard.channelchek.com/wp-content/uploads/pdf/CRDF_20260105_27958.pdf (open research)
- 10.11
- https://mcp.us-cm-kg.ai/record/NASDAQ/CRDF (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US14147L1089"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:4cbb59c0f8ef5962.